Powered by

Who's winning Brent Saunder's dealmaking business

Oct 04, 2016 - The Deal Pipeline
Mergers and Acquisitions

As Allergan plc (AGN) makes good on its so-called stepping stone M&A strategy, announcing Monday its sixth deal since completing its generics sale to Teva Pharmaceutical Industries Ltd. (TEVA) in early August, a number of advisory firms are continuing to rake in the fees from Brent Saunders' dealmaking business. 

Weil Gotshal & Manges LLP, Debevoise & Plimpton LLP and Covington & Burling LLP are largely behind Allergan's recent slew of tuck-in deals.